Results 111 to 120 of about 2,131 (185)

Real-World Clinical Effectiveness and Migraine-Related Healthcare Resource Utilization in Patients Initiating Fremanezumab in Germany and the United Kingdom. [PDF]

Ther Clin Risk Manag
Heinze A, Afridi SK, Totev TI, Krasenbaum LJ, Terasawa E, Akcicek H, Hipp J, Dhiraj D, Sun R, Yim E, Yilma B, Driessen MT.   +11 more
europepmc   +1 more source

Prescriber adherence to treatment guidelines for monoclonal antibodies against Calcitonin Gene-Related Peptide in migraine prophylaxis - a register-based cohort study. [PDF]

J Headache Pain
Nordenmalm S, Malmström RE, Freyland S, Nilsson Remahl AIM, Wirdefeldt K, Ekheden I.   +5 more
europepmc   +1 more source

CGRP-targeted migraine treatment and early pathophysiology in experimental subarachnoid hemorrhage. [PDF]

J Headache Pain
Fungbrant EP, Bömers JP, Reducha PV, Kazantzi S, Mathiesen T, Edvinsson L, Haanes KA.   +6 more
europepmc   +1 more source

Retrospective Review of Dual CGRP-Targeted Regimens for Acute and Preventive Treatment of Migraines in a Veteran Population. [PDF]

Fed Pract
Forrest A, Billow D, Martin A.
europepmc   +1 more source

Delayed urticaria during treatment with anti-CGRP monoclonal antibodies in migraine. [PDF]

Headache
Berger CT, Villena FB, Vogt SB, Heydrich L, Hartmann K, Papadopoulou A.   +5 more
europepmc   +1 more source

Efficacy and safety of CGRP monoclonal antibodies in chronic migraine: a systematic review integrating randomized and real-world evidence. [PDF]

Neurol Sci
Carta D, Lo Buono V, Grugno R, Lo Presti R, Quartarone A, Marino S.   +5 more
europepmc   +1 more source

Real-World Effectiveness and Safety of Anti-CGRP Monoclonal Antibodies in the Prevention of High-Frequency Episodic and Chronic Migraine in Romania-A Multicenter Retrospective Observational Study. [PDF]

Biomedicines
Ciubotaru A, Vamanu A, Grosu C, Constantinescu V, Ignat EB, Cucu LE, Alexa D, Mastaleru A, Pana BI, Antochi F, Roceanu AM.   +10 more
europepmc   +1 more source

Drugs for Migraine Prophylaxis. [PDF]

Dtsch Arztebl Int
Diener HC, Grans J, Reuter U.
europepmc   +1 more source

CGRP-pathway exposure during the pre-EBP interval in spontaneous intracranial hypotension: an exploratory retrospective case series. [PDF]

BMC Neurol
Yin CY, Chang KH, Hsu YC, An YC, Yang IF, Yang FC.   +5 more
europepmc   +1 more source

Comparing the Efficacy and Safety of Anti-CGRP Monoclonal Antibodies Versus Topiramate for Migraine Prophylaxis: Six-Month, Real-World, Intention-to-Treat Retrospective Evidence from the GRASP Study Group. [PDF]

Neurol Int
Vikelis M, Rikos D, Argyriou AA, Soldatos P, Tsironis C, Giakoumakis E, Xiromerisiou G, Chondrogianni M, Foska A, Koutsokera M, Notas K, Mavraki E, Dermitzakis EV, Greek Research Alliance for the Study of Headache and Pain (GRASP) Study Group.   +13 more
europepmc   +1 more source